Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation

Stewart, 2005, Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection, J Heart Lung Transplant, 24, 1710, 10.1016/j.healun.2005.03.019 Hammond, 2005, Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies, J Heart Lung Transplant, 24, 2015, 10.1016/j.healun.2005.08.014 Colvin, 2005, Antibody-mediated organ-allograft rejection, Nat Rev Immunol, 5, 807, 10.1038/nri1702 Takemoto, 2004, National conference to assess antibody-mediated rejection in solid organ transplantation, Am J Transplant, 4, 1033, 10.1111/j.1600-6143.2004.00500.x Fedrigo, 2010, Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients?, Transplantation, 90, 791, 10.1097/TP.0b013e3181efd059 Moseley, 2010, Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy, J Heart Lung Transplant, 29, 417, 10.1016/j.healun.2009.12.018 Poelzl, 2005, Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy, Transpl Int, 18, 313, 10.1111/j.1432-2277.2004.00037.x Crary, 2010, Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study, Transplantation, 90, 1099, 10.1097/TP.0b013e3181f7fec9 Almuti, 2007, The changing pattern of humoral rejection in cardiac transplant recipients, Transplantation, 84, 498, 10.1097/01.tp.0000278094.41131.9f Kfoury, 2006, Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns, J Heart Lung Transplant, 25, 1277, 10.1016/j.healun.2006.08.009 Angelini, 2008, Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation, J Heart Lung Transplant, 27, 1357, 10.1016/j.healun.2008.09.004 Ho, 2011, Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival, Hum Immunol, 72, 5, 10.1016/j.humimm.2010.10.013 Solez, 2008, Banff 07 classification of renal allograft pathology: updates and future directions, Am J Transplant, 8, 753, 10.1111/j.1600-6143.2008.02159.x Colvin, 2010, Dimensions of antibody-mediated rejection, Am J Transplant, 10, 1509, 10.1111/j.1600-6143.2010.03172.x Tan, 2010, Diagnosis of antibody-mediated rejection in cardiac transplantation: a call for standardization, Curr Opin Organ Transplant, 15, 769, 10.1097/MOT.0b013e32834016e4 Smith, 2007, C4d fixing, Luminex binding antibodies—a new tool for prediction of graft failure after heart transplantation, Am J Transplant, 7, 2809, 10.1111/j.1600-6143.2007.01991.x Rodriguez, 2005, Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers, Am J Transplant, 5, 2778, 10.1111/j.1600-6143.2005.01074.x Sis, 2010, Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups, Am J Transplant, 10, 464, 10.1111/j.1600-6143.2009.02987.x Rose, 2009, Clinical relevance of complement-fixing antibodies in cardiac transplantation, Hum Immunol, 70, 605, 10.1016/j.humimm.2009.04.016 Kobashigawa, 2011, Report from a consensus conference on antibody-mediated rejection in heart transplantation, J Heart Lung Transplant, 30, 252, 10.1016/j.healun.2010.11.003 Berry, 2011, The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005–2011), J Heart Lung Transplant, 30, 601, 10.1016/j.healun.2011.02.015 Caforio, 2004, Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression, Am J Transplant, 4, 962, 10.1111/j.1600-6143.2004.00434.x Bohmig, 2002, Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury, J Am Soc Nephrol, 13, 1091, 10.1681/ASN.V1341091 Chantranuwat, 2004, Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence, Appl Immunohistochem Mol Morphol, 12, 166, 10.1097/00129039-200406000-00012 Colombo, 2007, Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine, Cytometry B Clin Cytom, 72, 465, 10.1002/cyto.b.20353 Mizutani, 2007, The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients, Am J Transplant, 7, 1027, 10.1111/j.1600-6143.2006.01721.x Deeks, 2004, Diagnostic tests 4: likelihood ratios, BMJ, 329, 168, 10.1136/bmj.329.7458.168 Wu, 2009, Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes, J Heart Lung Transplant, 28, 417, 10.1016/j.healun.2009.01.015 Kucirka, 2010, Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies, Cardiovasc Pathol, 20, 132, 10.1016/j.carpath.2010.03.008 Michaels, 2003, Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease, J Heart Lung Transplant, 22, 58, 10.1016/S1053-2498(02)00472-2 Tavora, 2011, Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection, J Heart Lung Transplant, 30, 435, 10.1016/j.healun.2010.10.009